Novel human histone deacetylases
CA 2450129 A1 · Owner: Lorenzi, Matthew V. · Inventors: Jackson, Donald G.; Lorenzi, Matthew V.; Gottardis, Marco
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to newly discovered human histone deacetylases (HDACs), also referred to as histone deacetylase-like polypeptides. The polynucleotide sequences and encoded polypeptides of the novel HDACs are encompassed by the invention, as well as vectors comprising these polynucleotides and host cells comprising these vectors. The invention also relates to antibodies that bind to the disclosed HDAC polypeptides and , methods employing these antibodies. Also related are methods of screening for modulators, such as inhibitors or antagonists or agonists. The invention also , relates to diagnostic and therapeutic applications which employ the disclosed HDAC …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 14, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 14, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 14, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.